Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule

Journal of Experimental Medicine

Volumn 191, Issue 11, 2000, Pages 1987-1997

  Riley, James L ^a   Schlienger, Katia ^a   Blair, Patrick J ^b   Carreno, Beatriz ^c   Craighead, Nancy ^b   Kim, Daniel ^d   Carroll, Richard G ^a   June, Carl H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c PFIZER INC   (United States)

^d HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Chemokine receptors; Chemokines; Costimulation; HIV; T cells

Indexed keywords

CD28 ANTIGEN; LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES, CC; DOWN-REGULATION; HIV-1; HUMANS; IMMUNOCONJUGATES; PHYTOHEMAGGLUTININS; RECEPTORS, CCR5; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034608715     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.11.1987     Document Type: Article

References (57)

1. Zagury, D., J. Bernard, R. Leonard, R. Cheynier, M. Feldman, P.S. Sarin, and R.C. Gallo. 1986. Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 231:850-853.
2. Zack, J.A., A.J. Cann, J.P. Lugo, and I.S. Chen. 1988. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science. 240:1026-1029.
3. Korin, Y.D., and J.A. Zack. 1998. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72:3161-3168.
4. Kinoshita, S., B.K. Chen, H. Kaneshima, and G.P. Nolan. 1998. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell. 95:595-604.
5. Chambers, C.A., and J.P. Allison. 1997. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9:396-404.
6. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
7. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
8. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science. 272:1939-1943.
9. Connor, R.I., K.E. Sheridan, D. Ceradini, S. Choe, and N.R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-628.
10. Riley, J.L., R.G. Carroll, B.L. Levine, W. Bernstein, D.C. St. Louis, O.S. Weislow, and C.H. June. 1997. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158:5545-5553.
11. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1997. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J. Immunol. 159:5441-5449.
12. + T cells. Science. 276:273-276.
13. Riley, J.L., B.L. Levine, N. Craighead, T. Francomano, D. Kim, R.G. Carroll, and C.H. June. 1998. Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implications for transmission and pathogenesis. J. Virol. 72:8273-8280.
14. + T cells. Science. 270:1811-1815.
15. Linsley, P.S., J.L. Greene, P. Tan, J. Bradshaw, J.A. Ledbetter, C. Anasetti, and N.K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595-1604.
16. Perkins, D., Z. Wang, C. Donovan, H. He, D. Mark, G. Guan, Y. Wang, T. Walunas, J. Bluestone, and J. Listman. 1996. Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156:4154-4159.
17. van der Merwe, P.A., D.L. Bodian, S. Daenke, P. Linsley, and S.J. Davis. 1997. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185:393-403.
18. Thompson, C.B., and J.P. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity. 7:445-450.
19. + T cells. Immunity. 7:885-895.
20. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
21. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988.
22. Walunas, T.L., C.Y. Bakker, and J.A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541-2550.
23. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155: 1032-1036.
24. Krummel, M.F., and J.P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-465.
25. June, C.H., J.A. Ledbetter, M.M. Gillespie, T. Lindsten, and C.B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472-4481.
26. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
27. Hansen, J.A., P.J. Martin, and R.C. Nowinski. 1980. Monoclonal antibodies identifying a novel T-cell antigen and Ia antigens of human lymphocytes. Immunogenetics. 10:247-260.
28. Gribben, J.G., G.J. Freeman, V.A. Boussiotis, P. Rennert, C.L. Jellis, E. Greenfield, M. Barber, V.A.J. Restivo, X. Ke, and G.S. Gray. 1995. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA. 92:811-815.
29. L induction. J. Immunol. 160:12-15.
30. Mascola, J.R., J. Louwagie, F.E. McCutchan, C,.L. Fischer, P.A. Hegerich, K.F. Wagner, A.K. Fowler, J.G. McNeil, and D.S. Burke. 1994. Two antigeincally distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
31. Adachi, A., H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
32. Vahey, M.T., and M.T. Wong. 1995. Quantative liquid hybridization employing phosphor technology. In PCR Primer: A Laboratory Manual. C.W. Dieffenbach and G.S. Dveksler, editors. Cold Spring Harbor Laboratory Press. Plainview, NY. 313.
33. Vahey, M.T., M.T. Wong, and N.L. Michael. 1995. A standard PCR protocol: rapid isolation of DNA and PCR assay for β-globin. In PCR Primer: A Laboratory Manual. C.W. Dieffenbach and G.S. Dveksler, editors. Cold Spring Harbor Laboratory Press, Plainview, NY. 17.
34. Riley, J.L., and R.G. Carroll. 1998. Quantitation of HIV-1 cofactor expression. In HIV Protocols. N.L. Michael and J.H. Kim, editors. Humana Press, Totowa, NJ. 219-226.
35. Bleul, C.C., L. Wu, J.A. Hoxie, T.A. Springer, and C.R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA. 94:1925-1930.
36. Stevenson, M., T.L. Stanvick, M.P. Dempsey, and C.A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO (Eur. Mol. Biol. Organ.) J. 9:1551-1560.
37. + lymphocytes. J. Immunol. 142:773-780.
38. Ledbetter, J.A., J.B. Imboden, G.L. Schieven, L.S. Grosmaire, P.S. Rabinovitch, T. Lindsten, C.B. Thompson, and C.H. June. 1990. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood. 75:1531-1539.
39. Gimmi, C.D., G.J. Freeman, J.G. Gribben, G. Gray, and L.M. Nadler. 1993. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA. 90:6586-6590.
40. + T cells is markedly enhanced in the setting of antigen-specific immune activation. J. Exp. Med. 183:687-692.
41. Robbins, P.A., G.L. Roderiquez, K.W. Peden, and M.A. Norcross. 1998. Human immunodeficiency virus type 1 intection of antigen-specific CD4 cytotoxic T lymphocytes. AIDS Res. Hum. Retroviruses. 14:1397-1406.
42. Feng, Y., C.C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:872-877.
43. Tan, P., C. Anasetti, J.A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J.A. Ledbetter, and P.S. Linsley. 1993. Induction of alloantigen-specitic hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165-173.
44. Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405-413.
45. Moriuchi, H., M. Moriuchi, and A.S. Fauci. 1999. Induction of HIV-1 replication by allogeneic stimulation. J. Immunol. 162:7543-7548.
46. Pope, M., M.G. Betjes, N. Romani, H. Hirmand, P.U. Cameron, L. Hoffman, S. Gezelter, G. Schuler, and R.M. Steinman. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 78:389-398.
47. Pinchuk, L.M., P.S. Polacino, M.B. Agy, S.J. Klaus, and E.A. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity. 1:317-325.
48. + T cells down-regulates the expression of CD28: effect on T cell activation and cytokine production. Clin. Immunol. Immunopathol. 77:262-270.
49. Lee, K.M., E. Chuang, M. Griffin, R. Khattri, D.K. Hong, W. Zhang, D. Straus, L.E. Samelson, C.B. Thompson, and J.A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science. 282:2263-2266.
50. + T cells. J. Exp. Med. 188:1849-1857.
51. Li, J.M., X. Shen, P.P. Hu, and X.F. Wang. 1998. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity. Mol. Cell. Biol. 18:110-121.
52. Brocker, T. 1997. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J. Exp. Med. 186:1223-1232.
53. Kirberg, J., A. Berns, and H. von Boehmer. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J. Exp. Med. 186:1269-1275.
54. + T cells. Science. 286:1353-1357.
55. + T cells in HIV infection. Clin. Exp. Immunol. 115:451-457.
56. Tam, R.C., U.T. Phan, T. Milovanovic, B. Pai, C. Lim, J. Bard, and L. He. 1997. Oligonucleotide-mediated inhibition of CD28 expression induces human T cell hyporesponsiveness and manifests impaired contact hypersensitivity in mice. J. Immunol. 158:200-208.
57. Daikh, D., D. Wofsy, and J.B. Imboden. 1997. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J. Leukoc. Biol. 62:156-162.